Insider Transactions in Q1 2025 at Eli Lilly & CO (LLY)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
35,446
-0.01%
|
$31,192,480
$880.55 P/Share
|
|
Feb 10
2025
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
6,828
+8.43%
|
$5,926,704
$868.88 P/Share
|
|
Feb 10
2025
|
Ilya Yuffa EVP & President, LLY Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
7,123
+19.85%
|
$6,182,764
$868.88 P/Share
|
|
Feb 10
2025
|
Lucas Montarce EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,895
+17.17%
|
$2,512,860
$868.88 P/Share
|
|
Feb 10
2025
|
Diogo Rau EVP & CIDO |
BUY
Grant, award, or other acquisition
|
Direct |
6,815
+25.69%
|
$5,915,420
$868.88 P/Share
|
|
Feb 10
2025
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
BUY
Grant, award, or other acquisition
|
Direct |
6,103
+23.78%
|
$5,297,404
$868.88 P/Share
|
|
Feb 10
2025
|
Eric Dozier EVP, HR & Diversity |
BUY
Grant, award, or other acquisition
|
Direct |
919
+9.3%
|
$797,692
$868.88 P/Share
|
|
Feb 10
2025
|
Donald A Zakrowski SVP, Finance, & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+16.58%
|
$1,179,612
$868.88 P/Share
|
|
Feb 10
2025
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,974
+13.53%
|
$5,185,432
$868.88 P/Share
|
|
Feb 10
2025
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
BUY
Grant, award, or other acquisition
|
Direct |
7,170
+11.79%
|
$6,223,560
$868.88 P/Share
|
|
Feb 10
2025
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Grant, award, or other acquisition
|
Direct |
18,771
+12.08%
|
$16,293,228
$868.88 P/Share
|
|
Feb 10
2025
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Open market or private sale
|
Direct |
5,000
-1.37%
|
$4,320,000
$864.14 P/Share
|
|
Feb 10
2025
|
Anat Hakim EVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
10,320
+26.36%
|
$8,957,760
$868.88 P/Share
|
|
Feb 10
2025
|
David A Ricks President, Chair, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
55,131
+9.27%
|
$47,853,708
$868.88 P/Share
|
|
Feb 06
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.01%
|
$183,960,000
$876.89 P/Share
|
|
Feb 01
2025
|
David A Ricks President, Chair, and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,903
-2.4%
|
$9,653,333
$811.08 P/Share
|
|
Feb 01
2025
|
David A Ricks President, Chair, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,561
+5.08%
|
-
|
|
Feb 01
2025
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Payment of exercise price or tax liability
|
Direct |
4,003
-3.15%
|
$3,246,433
$811.08 P/Share
|
|
Feb 01
2025
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Exercise of conversion of derivative security
|
Direct |
8,989
+6.62%
|
-
|
|
Feb 01
2025
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,409
-9.48%
|
$1,142,699
$811.08 P/Share
|
|
Feb 01
2025
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,023
+16.9%
|
-
|
|
Feb 01
2025
|
Anne E. White EVP & Pres, Lilly Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
1,457
-2.12%
|
$1,181,627
$811.08 P/Share
|
|
Feb 01
2025
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
3,269
+4.53%
|
-
|
|
Feb 01
2025
|
Ilya Yuffa EVP & President, LLY Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
1,434
-6.22%
|
$1,162,974
$811.08 P/Share
|
|
Feb 01
2025
|
Ilya Yuffa EVP & President, LLY Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
3,269
+12.41%
|
-
|
|
Feb 01
2025
|
Anat Hakim EVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,166
-10.47%
|
$1,756,626
$811.08 P/Share
|
|
Feb 01
2025
|
Anat Hakim EVP, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,904
+19.17%
|
-
|
|
Feb 01
2025
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,281
-3.83%
|
$1,038,891
$811.08 P/Share
|
|
Feb 01
2025
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,861
+7.87%
|
-
|
|
Feb 01
2025
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,535
-3.2%
|
$1,244,885
$811.08 P/Share
|
|
Feb 01
2025
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
BUY
Exercise of conversion of derivative security
|
Direct |
3,433
+6.67%
|
-
|
|
Feb 01
2025
|
Diogo Rau EVP & CIDO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,466
-10.2%
|
$1,188,926
$811.08 P/Share
|
|
Feb 01
2025
|
Diogo Rau EVP & CIDO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,269
+18.53%
|
-
|
|
Jan 21
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,130
$742.35 P/Share
|
|
Jan 21
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$9,646
$742.35 P/Share
|
|
Jan 21
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.68%
|
$9,646
$742.35 P/Share
|
|
Jan 21
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,098
$742.35 P/Share
|
|
Jan 21
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.24%
|
$4,452
$742.35 P/Share
|